Annual short term debt:
$92.30M+$8.60M(+10.27%)Summary
- As of today (August 24, 2025), VRTX annual short term debt is $92.30 million, with the most recent change of +$8.60 million (+10.27%) on December 31, 2024.
- During the last 3 years, VRTX annual short term debt has risen by +$12.10 million (+15.09%).
- VRTX annual short term debt is now -71.10% below its all-time high of $319.43 million, reached on December 31, 2016.
Performance
VRTX Short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly short term debt:
$0.00$0.00(0.00%)Summary
- As of today (August 24, 2025), VRTX quarterly short term debt is $0.00, unchanged on June 30, 2025.
- Over the past year, VRTX quarterly short term debt has stayed the same.
- VRTX quarterly short term debt is now -100.00% below its all-time high of $319.43 million, reached on December 31, 2016.
Performance
VRTX quarterly short term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Short term debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VRTX Short term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.3% | 0.0% |
| 3 y3 years | +15.1% | 0.0% |
| 5 y5 years | +83.5% | 0.0% |
VRTX Short term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.1% | -100.0% | at low |
| 5 y | 5-year | at high | +83.5% | -100.0% | at low |
| alltime | all time | -71.1% | >+9999.0% | -100.0% | at low |
VRTX Short term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $0.00(0.0%) |
| Mar 2025 | - | $0.00(-100.0%) |
| Dec 2024 | $92.30M(+10.3%) | $92.30M(>+9900.0%) |
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $83.70M(-6.4%) | $83.70M(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $89.40M(+11.5%) | $89.40M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $80.20M(+51.4%) | $80.20M(>+9900.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $52.95M(+5.3%) | $52.95M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $50.30M(+412.4%) | $50.30M(+11.1%) |
| Sep 2019 | - | $45.26M(+0.6%) |
| Jun 2019 | - | $44.99M(+4.0%) |
| Mar 2019 | - | $43.24M(+340.5%) |
| Dec 2018 | $9.82M(-56.4%) | $9.82M(-14.7%) |
| Sep 2018 | - | $11.51M(-23.6%) |
| Jun 2018 | - | $15.06M(-11.0%) |
| Mar 2018 | - | $16.92M(-24.9%) |
| Dec 2017 | $22.53M(-92.9%) | $22.53M(+13.3%) |
| Sep 2017 | - | $19.88M(+9.4%) |
| Jun 2017 | - | $18.18M(-5.7%) |
| Mar 2017 | - | $19.27M(-94.0%) |
| Dec 2016 | $319.43M(+267.1%) | $319.43M(+1.2%) |
| Sep 2016 | - | $315.52M(+32.0%) |
| Jun 2016 | - | $239.02M(+46.2%) |
| Mar 2016 | - | $163.54M(+87.9%) |
| Dec 2015 | $87.02M(+171.8%) | $87.02M(+514.9%) |
| Sep 2015 | - | $14.15M(-75.1%) |
| Jun 2015 | - | $56.79M(+17.8%) |
| Mar 2015 | - | $48.20M(+50.6%) |
| Dec 2014 | $32.01M(+89.5%) | $32.01M(+76.6%) |
| Sep 2014 | - | $18.12M(-8.0%) |
| Jun 2014 | - | $19.71M(+7.6%) |
| Mar 2014 | - | $18.32M(+8.5%) |
| Dec 2013 | $16.89M(+23.2%) | $16.89M(+17.1%) |
| Sep 2013 | - | $14.43M(+35.3%) |
| Jun 2013 | - | $10.66M(+28.5%) |
| Mar 2013 | - | $8.30M(-39.4%) |
| Dec 2012 | $13.71M(>+9900.0%) | $13.71M(>+9900.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $98.42M(+4.0%) |
| Jun 2011 | - | $94.66M(+2.8%) |
| Mar 2011 | - | $92.10M(-32.8%) |
| Dec 2010 | $136.99M(+327.1%) | $136.99M(+202.5%) |
| Sep 2010 | - | $45.28M(-1.1%) |
| Jun 2010 | - | $45.78M(>+9900.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $32.07M(>+9900.0%) | $32.07M(>+9900.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $20.00M(0.0%) |
| Dec 2007 | $20.00M(-80.3%) | $20.00M(0.0%) |
| Sep 2007 | - | $20.00M(-67.8%) |
| Jun 2007 | - | $62.10M(+47.5%) |
| Mar 2007 | - | $42.10M(-58.6%) |
| Dec 2006 | $101.75M(>+9900.0%) | $101.75M(+141.7%) |
| Sep 2006 | - | $42.10M(>+9900.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2004 | - | $4.69M(0.0%) |
| Jun 2004 | - | $4.69M(-66.6%) |
| Mar 2004 | - | $14.04M(-24.8%) |
| Dec 2003 | $18.66M(+750.1%) | $18.66M(+4112.2%) |
| Sep 2003 | - | $443.00K(-47.6%) |
| Jun 2003 | - | $846.00K(-38.4%) |
| Mar 2003 | - | $1.37M(-37.4%) |
| Dec 2002 | $2.19M(-52.1%) | $2.19M(-26.1%) |
| Sep 2002 | - | $2.97M(-15.6%) |
| Jun 2002 | - | $3.52M(-10.4%) |
| Mar 2002 | - | $3.93M(-14.2%) |
| Dec 2001 | $4.58M(+92.6%) | $4.58M(+0.4%) |
| Sep 2001 | - | $4.56M(+126.3%) |
| Jun 2001 | - | $2.02M(-7.8%) |
| Mar 2001 | - | $2.19M(-8.0%) |
| Dec 2000 | $2.38M(+0.5%) | $2.38M(-98.5%) |
| Sep 2000 | - | $163.80M(+7331.9%) |
| Jun 2000 | - | $2.20M(-3.0%) |
| Mar 2000 | - | $2.27M(-4.0%) |
| Dec 1999 | $2.37M(-14.0%) | $2.37M(-3.5%) |
| Sep 1999 | - | $2.45M(-4.3%) |
| Jun 1999 | - | $2.56M(-4.2%) |
| Mar 1999 | - | $2.67M(-2.9%) |
| Dec 1998 | $2.75M(+9.6%) | $2.75M(-3.1%) |
| Sep 1998 | - | $2.84M(+6.0%) |
| Jun 1998 | - | $2.68M(+5.6%) |
| Mar 1998 | - | $2.54M(+1.5%) |
| Dec 1997 | $2.51M(-13.7%) | $2.50M(-7.4%) |
| Sep 1997 | - | $2.70M(-3.6%) |
| Jun 1997 | - | $2.80M(0.0%) |
| Mar 1997 | - | $2.80M(-3.4%) |
| Dec 1996 | $2.91M(+40.2%) | $2.90M(+16.0%) |
| Sep 1996 | - | $2.50M(+8.7%) |
| Jun 1996 | - | $2.30M(+9.5%) |
| Mar 1996 | - | $2.10M(0.0%) |
| Dec 1995 | $2.08M(+24.8%) | $2.10M(+10.5%) |
| Sep 1995 | - | $1.90M(+5.6%) |
| Jun 1995 | - | $1.80M(+5.9%) |
| Mar 1995 | - | $1.70M(0.0%) |
| Dec 1994 | $1.66M(-5.8%) | $1.70M(+6.3%) |
| Sep 1994 | - | $1.60M(0.0%) |
| Jun 1994 | - | $1.60M(0.0%) |
| Mar 1994 | - | $1.60M(-11.1%) |
| Dec 1993 | $1.77M(-3.5%) | $1.80M(-5.3%) |
| Sep 1993 | - | $1.90M(-5.0%) |
| Jun 1993 | - | $2.00M(+5.3%) |
| Mar 1993 | - | $1.90M(+5.6%) |
| Dec 1992 | $1.83M(+54.7%) | $1.80M(+5.9%) |
| Sep 1992 | - | $1.70M(+13.3%) |
| Jun 1992 | - | $1.50M(+15.4%) |
| Mar 1992 | - | $1.30M(+8.3%) |
| Dec 1991 | $1.18M(+47.9%) | $1.20M(+9.1%) |
| Sep 1991 | - | $1.10M(+10.0%) |
| Jun 1991 | - | $1.00M(+25.0%) |
| Dec 1990 | $800.00K | $800.00K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual short term debt?
- What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly short term debt?
- What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly short term debt year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual short term debt?
The current annual short term debt of VRTX is $92.30M
What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual short term debt is $319.43M
What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
Over the past year, VRTX annual short term debt has changed by +$8.60M (+10.27%)
What is Vertex Pharmaceuticals Incorporated quarterly short term debt?
The current quarterly short term debt of VRTX is $0.00
What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly short term debt is $319.43M
What is Vertex Pharmaceuticals Incorporated quarterly short term debt year-on-year change?
Over the past year, VRTX quarterly short term debt has changed by $0.00 (0.00%)